WHO Global InfoBase (http:www.infobase.who.int)
Стратегия профилактики и контроля неинфекционных заболеваний и травматизма в Российской Федерации, Москва, 2008.
Проект Федерального Закона «Об основах охраны здоровья граждан в Российской Федерации». http://zakonoproekt2011.minzdravsoc.ru/project
Московская декларация, принятая по итогам работы Первой глобальной Министерской конференции по здоровому образу жизни и неинфекционным заболеваниям (28-29 апреля 2011 г.). http://www.minzdravsoc.ru/health/zozh/71
Заболеваемость населения России в 2007 году. Статистические материалы, Москва, 2008.
Bertuccio P, Levi F, Lucchini F, Chatenoud L, Bosetti C, Negri E, La Vecchia C. Coronary heart disease and cerebrovascular disease mortality in young adults: recent trends in Europe European Journal of Cardiovascular Prevention & Rehabilitation August 2011 18: 627-634.
Статистический сборник “Краткосрочные экономические показатели Российской Федерации”, Госкомстат России. Москва, 2008.
Оганов Р.Г., Масленникова Г.Я.. Эпидемию сердечно-сосудистых заболеваний можно остановить усилением профилактики. Профилактическая медицина том 12 №6 2009 3-7.
Кардиология. Национальное руководство. Под редакцией Ю.Н.Беленкова, Р.Г.Оганова. «ГЭОТАР-Медиа». Москва 2007, с.43-39.
Yusuf S, Hawken S, Ounpu S, et al., on behalf of the INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART Study): case-control study. www.thelancet.com. Published online September, 3 2004.
O'Donnell M, Xavier D, Liu L, Zhang H. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE Study): a case-control study Reference: Lancet 2010; 376:112-123.
Чазов Е.И., Оганов Р.Г., Погосова Г.В. и соавт. Клинико-эпидемиологическая программа изучения депрессии в кардиологической практике: у больных артериальной гипертонией и ишемической болезнью сердца (КООРДИНАТА): результаты многоцентрового исследования. Кардиология 2007;3: 28-37.
Rose G. The strategy of preventive medicine/ Oxford: Oxford University Press 1992.
Global strategy for prevention and control of non-comminicable diseases. WHO (Geneva) 2008.
Wood D, De Backer G, Faergeman O, Graham I, Mancia G, Pyörälä K. Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on coronary prevention. Eur Heart J. 1998 Oct;19(10):1434-503.
De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J, Ebrahim S, Faergeman O, Graham I, Mancia G, Cats VM, Orth-Gomér K, Perk J, Pyörälä K, Rodicio JL, Sans S, Sansoy V, Sechtem U, Silber S, Thomsen T, Wood D; European Society of Cardiology Committee for Practice Guidelines. European guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts). Eur J Cardiovasc Prev Rehabil. 2003 Aug;10(4):S1-S78.
Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, Dallongeville J, De Backer G, Ebrahim S, Gjelsvik B, Herrmann-Lingen C, Hoes A, Humphries S, Knapton M, Perk J, Priori SG, Pyorala K, Reiner Z, Ruilope L, Sans-Menendez S, Op Reimer WS, Weissberg P, Wood D, Yarnell J, Zamorano JL, Walma E, Fitzgerald T, Cooney MT, Dudina A, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Funck-Brentano C, Filippatos G, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Altiner A, Bonora E, Durrington PN, Fagard R, Giampaoli S, Hemingway H, Hakansson J, Kjeldsen SE, Larsen L, Mancia G, Manolis AJ, Orth-Gomer K, Pedersen T, Rayner M, Ryden L, Sammut M, Schneiderman N, Stalenhoef AF, Tokgözoglu L, Wiklund O, Zampelas A; European Society of Cardiology (ESC); European Association for Cardiovascular Prevention and Rehabilitation (EACPR); Council on Cardiovascular Nursing; European Association for Study of Diabetes (EASD); International Diabetes Federation Europe (IDF-Europe); European Stroke Initiative (EUSI); Society of Behavioural Medicine (ISBM); European Society of Hypertension (ESH); WONCA Europe (European Society of General Practice/Family Medicine); European Heart Network (EHN); European Atherosclerosis Society (EAS).European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil. 2007 Sep;14 Suppl 2:S1-113.
Ощепкова Е.В. Смертность населения от сердечно-сосудистых заболеваний в Российской Федерации в 2001-2006 гг. и пути по ее снижению. Кардиология, 2, 2009, 67-72.
Бойцов С.А., Довгалевский П.Я., Гриднев В.И. и соавт. Сравнительный анализ данных Российского и зарубежных регистров острого коронарного синдрома. Кардиологический вестник 2010; 1: 82-86.
Kotseva K, Wood D, De Backer G, De Bacquer D, Pyörälä K, Reiner Z, Keil U; EUROASPIRE Study Group.EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: cross-sectional survey in 12 European countries. Eur J Cardiovasc Prev Rehabil. 2010 Oct;17(5):530-40.
Puska P, Tuomilehto J, Nissinen A, Vartiainen E. The North Karelia Project 20 Year Results and Experience. National Public Health Institute, KTL Helsinki, 1995. – P. 221-223.
Оганов Р.Г., Масленникова Г.Я., Колтунов И.Е., Калинина А.М. Необходимые условия для профилактики сердечно-сосудистых заболеваний в Российской Федерации. Кардиоваскулярная терапия и профилактика 2010;6: 4-9.
Современные стратегии профилактики и лечения сердечно-сосудистых заболеваний. Р.Г. Оганов, Г.В. Погосова, Кардиология 2007; 12; 4–9.
Reiner Z, Catapano AL, De Backer G, Graham I, Taskinen MR, Wiklund O, Agewall S, Alegria E, Chapman MJ, Durrington P, Erdine S, Halcox J, Hobbs R, Kjekshus J, Filardi PP, Riccardi G, Storey RF, Wood D; ESC Committee for Practice Guidelines (CPG) 2008-2010 and 2010-2012 Committees, Bax J, Vahanian A, Auricchio A, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Filippatos G, Funck-Brentano C, Hasdai D, Hobbs R, Hoes A, Kearney P, Knuuti J, Kolh P, McDonagh T, Moulin C, Poldermans D, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vardas P, Widimsky P, Windecker S, Reviewers D, Funck-Brentano C, Poldermans D, Berkenboom G, De Graaf J, Descamps O, Gotcheva N, Griffith K, Guida GF, Gulec S, Henkin Y, Huber K, Kesaniemi YA, Lekakis J, Manolis AJ, Marques-Vidal P, Masana L, McMurray J, Mendes M, Pagava Z, Pedersen T, Prescott E, Rato Q, Rosano G, Sans S, Stalenhoef A, Tokgozoglu L, Viigimaa M, Wittekoek ME, Zamorano JL. ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Developed with the special contribution of: European Association for Cardiovascular Prevention & Rehabilitation. Eur Heart J. 2011 Jul;32(14):1769-818.
Wilson PWF, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 1998;97:1837-47.
National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002 Dec 17;106(25):3143-421.
Dawber TR, Meadors GF, Moore FE, Jr. Epidemiological approaches to heart disease: the Framingham Study. Am J Public Health 1951; 41(3):279-286.
Anderson KM, Castelli WP, Levy D. Cholesterol and mortality: 30 years of follow-up from the Framingham Study. JAMA 1987;257:2176-80.
Assmann G. Calculating global risk: the key to intervention. Eur Heart J Suppl (July 2005) 7(suppl F): F9-F14.
Vartiainen E, Jousilahti P, Alfthan G, et al. Cardiovascular risk factor changes in Finland 1972–1997. Int J Epidemiol 2000; 29: 49–56.
Conroy RM, Pyörälä K, Fitzgerald AP, Sans S, Menotti A, De Backer G, De Bacquer D, Ducimetière P., Jousilahti P., Keil U., Njølstad I., Oganov R.G., Thomsen T., Tunstall-Pedoe H., Tverdal A, Wedel H, Whincup P, Wilhelmsen L, Graham IM. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J (2003) 24(11): 987-1003.
Cooney MT, Dudina A, De Bacquer D, Fitzgerald A, Conroy R, Sans S, Menotti A, De Backer G, Jousilahti P, Keil U, Thomsen T, Whincup P, Graham I, on behalf of the SCORE investigators. How much does HDL cholesterol add to risk estimation? A report from the SCORE investigators. Eur J Cardiovasc Prev Rehabil. 2009 Jun;16(3):304-14.
Концепция демографической политики Российской Федерации до 2025 г.
Масленникова Г.Я., Оганов Р.Г. Влияние курения на здоровье населения: место России в Европе. Профилактика заболеваний и укрепление здоровья 2002; 6:17-20.
Peto R, Lopez AD, Boreham J, Thun M. Mortality from smoking in developed countries 1950-2000 (2nd edition revised June 2006) www.deathsfromsmoking.net
Оганов Р.Г., Масленникова Г.Я., Шальнова С.А., Деев А.Д. Сердечно-сосудистые и другие хронические неинфекционные заболевания: ситуация и возможности профилактики в России. Международный медицинский журнал 2003;9(1):16-21.
Shalnova S.A. Deev A.D., Zhukovsky G.S., Shestov D.B. Smoking and mortality in Russian Lipid Research Clinic sample. 1nd European congress on tobacco or health, Helsinki, Finland, 1996, Abstr. P. 95-96.
Масленникова Г.Я., Мартынчик С.А., Шальнова С.А., Деев А.Д., Оганов Р.Г. Медицинские и социально-экономические потери, обусловленные курением взрослого населения России. Профилактика Заболеваний и Укрепление Здоровья 2004; 3:5-9.
Оганов Р.Г., Шальнова С.А., Масленникова Г.Я., Деев А.Д. Роль здорового образа жизни в стратегии охраны здоровья населения. Российские медицинские вести 2001;3:34-37.
Gilmore A, Pomerleau J, McKee M, Rose R, Haerpfer CW, Rotman D, Tumanov S. Prevalence of Smoking in 8 Countries of the Former Soviet Union: Results From the Living Conditions, Lifestyles and Health Study. Am J Public Health 2004; 94:2177-2187.
Александров А.А., Шальнова С.А., Деев А.Д., Вихирева О.В., Ваганов А.Д., Рубченко И.А. Распространенность курения среди врачей г.Москвы. Вопросы наркологии 2001;3:67-71.
Шальнова С.А., Деев А.Д. Характеристика пациентов высокого риска. Результаты эпидемиологической части научно-образовательной программы ОСКАР. Кардиоваскулярная терапия и профилактика, 2006, 6, 58-63.
РЕЛИФ – РЕгулярное Лечение И проФилактика – ключ к улучшению ситуации с сердечно-сосудистыми заболеваниями в России: результаты российского многоцентрового исследования. Часть I. Оганов Р.Г., Погосова Г.В., Колтунов И.Е. и соавт. Кардиология 2007; 5: 58–66.
РЕЛИФ – РЕгулярное Лечение И проФилактика – ключ к улучшению ситуации с сердечно-сосудистыми заболеваниями в России: результаты российского многоцентрового исследования. Часть II Оганов Р.Г., Погосова Г.В., Колтунов И.Е Кардиология 2007; 62–71.
РЕЛИФ – РЕгулярное Лечение И проФилактика – ключ к улучшению ситуации с сердечно-сосудистыми заболеваниями в России: результаты российского многоцентрового исследования. Часть III Кардиология 2008; 4: 47–54.
Reddy KS, Yusuf S. Emerging epidemic of cardiovascular disease in developing countries. Circulation 1998; 97(6): 596-601.
Kenfield SA, Stampfer MJ, Rosner BA, Colditz GA. Smoking and smoking cessation in relation to mortality in women. JAMA. 2008;299:2037-2047.
Global burden of disease and injury series (edited by Murray CJL, Lopez AD, and Colin D). WHO publication (2004), vol. 4.
Масленникова Г.Я., Оганов Р.Г. Профилактика и снижение курения табака в России - реальные возможности улучшения демографической ситуации. Профилактика Заболеваний и Укрепление Здоровья 2008;3:3-10.
WHO Europe evidence based recommendations on the treatment of tobacco dependence. Tobacco control 2002;11:44-46.
Международная статистическая классификация болезней и проблем, связанных со здоровьем. Десятый пересмотрю Том 1 (часть 1). Всемирная организация здравоохранения. Женева. 1992. (698с.).
Fagerstrom KO. Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment. Addictive Behaviors. 1978;3(34):235–241.
Eisenberg M.J., Filion K.B., Yavin D. Et al. Pharmacotherapy for smoking cessation: a meta-analysis of randomized controlled trials. CMAJ 2008; 179(2): 135-144.
Rovina N. et al. Effectiveness of Pharmacotherapy and Behavioral Interventions for Smoking Cessation in Actual Clinical Practice. Ther Adv Resp Dis. 2009;3(6):279-287.
Wilson K., Gibson N., Willan A., Cook D. Effect of smoking cessation on mortality after myocardial infarction: meta-analysis of cohort studies.Arch Intern Med 2000; 160(7): 939-944.
Peto R, Darby S, Deo H, Silcocks P, Whitley E, Doll R. Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies. BMJ 2000;321(7257):323-329.
Critchley J.A., Capewell S. Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review. JAMA 2003; 290(1): 86-97.
Wannamethee S.G., Lowe G.D., Shaper A.G., Rumley A., Lennon L., Whincup P.H. Associations between cigarette smoking, pipe/cigar smoking, and smoking cessation, and haemostatic and inflammatory markers for cardiovascular disease. Eur Heart J 2005; 26(17): 1765-1773.
Iestra J.A. Kromhout D., van der Schouw Y.T., Grobbee D.E., Boshuizen H.C., and van Staveren W.A. Effect Size Estimates of Lifestyle and Dietary Changes on All-Cause Mortality in Coronary Artery Disease Patients: A Systematic Review. Circulation 2005; 112: 924-934.
Smith G.D., Phillips A.N., Neaton J.D. Smoking as «independent» risk factor for suicide: illustration of an artifact from observational epidemiology? Lancet 1992;340:749—752.
Государственный доклад «О санитарно-эпидемиологической обстановке в РФ в 2007 г»; 399с.
Н О Р М Ы физиологических потребностей в энергии и пищевых веществах для различных групп населения Российской Федерации . Утвержден руководителем Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека 18 декабря 2008 года.
Рацион, питание и предупреждение хронических заболеваний. Серия технических докладов ВОЗ; № 916, Женева; 2003; 186-196.
Тутельян В.А., Самсонов М.А. Справочник по диетологии. 2002; 544с.
Глобальная стратегия ВОЗ в области рациона питания, физической активности и здоровья Утверждена Всемирной ассамблеей здравоохранения, резолюция 57.17 от 22 мая 2004 года.
Еганян Р.А., Калинина А.М., Измайлова О.В. Источники энергетической ценности и вклад различных продуктов в обеспечении химического состава рациона неорганизованной популяции г. Москвы Вопросы питания, 2000, 5: 7-12.
Молчанова О.В., Бритов А.Н. Взаимосвязь пищевых факторов риска и уровня артериального давления в организованной популяции. Профилактика заболеваний и укрепление здоровья 2008; 6: 52-53.
Шальнова С.А., Деев А.Д., Вихирева О.В., Оганов Р.Г. Распространенность артериальной гипертонии в России. Информированность, лечение, контроль. Профилакт забол и укреп здор 2001; 2: 3–7.
Батурин А. К., Мартинчик А. Н., Сафронова А.М. и др. Питание в бедных семьях: взрослое трудоспособное население. Вопросы питания 2002; 71; 2: 3-7.
Тутельян В.А., Суханов Б.П., Васильев А.В. и др. Реализация концепции Государственной политики Здорового питания населения России на региональном уровне: формирование региональной политики и региональных программ. Методические аспекты разработки и реализации программ. Часть 1. Вопросы питания 2005; 74; 1: 3-7.
Hu F.B, Stampfer M.J, Rimm E.B, et al. A prospective study of egg consumption and risk of cardiovascular disease in men and women. JAMA 1999; 281: 1387-1394.
Hu F.B, Willett W.C. Optimal Diets for Prevention of Coronary Heart Disease. JAMA 2002; 288: 2569-2578.
Hooper L, Summerbell C.D, Thompson R.L, et al. Dietary fat intake and prevention of cardiovascular disease: systematic review. BMJ 2001; 322: 757-763.
Pietinen P, Ascherio A, Korhonen P, et al. Intake of fatty acids and risk of coronary heart disease in cohort of Finnish men. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Am J Epidemiol 1997; 145: 876-87.
Avellon G, Di Garbo V, Cordova R, et al. Effect of Mediterranean diet on lipid, coagulative and fibrinolytic parameters in two randomly selected population samples in Western Sicily. - Nutr Metab Cardiovasc Dis 1998; 8: 287-296.
Vincent-Baudry S, Defoort C, Gerber M, et al. The Medi-RIVAGE study reduction of cardiovascular disease risk factors after a 3-mo intervention with a Mediterranean-type diet or a low-fat diet. Am J Clin Nutr 2005; 82(5): 964-971.
Albert C.M, Hennekens C.H, O'Donnell C.J, et al. Fish consumption and risk of sudden cardiac death. JAMA 1998; 279: 23-28.
Din J.N, Newby D.E, Flapan A.D. Omega 3 fatty acids and cardiovascular disease – fishing for a natural treatment. BMJ 2004; 328: 30-35.
Vincent S., Gerber M., Bernard M.C. еt al .The Medi-Rivage study (Mediterranean Diet, Cardiovascular Risk a Gene Polymorphisms): rationale, recruitment, desighn, dietary intervention and baseline characteristics of participants. Public Health Nutr 2004; 7: 531-546.
Appel LJ, Brands MW, Daniels SR, et al. Dietary Approaches to prevent and treat hypertension 2006; 47: 296-308.
Arduser L., Brown D., Robert. A. Practical Guide Based on the USDA Food Code 2005.
Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. Intersalt Cooperative Research Group. BMJ 1988; 297: 319-328.
He F, Mac-Gregor G.A., Effect of modest salt reduction on blood pressure: a meta-analysis of randomized trials. Implication of public health. J Hum Hypertens 2002;16:761-770.
Chobanian A.V, Bakris G.L, Black H.R, Cushman W.C, et al. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003; 42:1206 –1252.
Moore T.J, Conlin PR, Ard J, et al. DASH (Dietary Approaches to Stop Hypertension) diet is effective treatment for stage 1 isolated systolic hypertension. Hypertension 2001; 38: 155-158.
Craddick S.R, Elmer P.J, Obarzanek E, Vollmer W.M, Svetkey L.P, Swain M.C. The DASH diet and blood pressure. Current Atherosclerosis Reports 5(6):484-491, November 2003.
Harsha D.W, Sacks F.M, Obarzanek E, Svetkey L.P, Lin P.H, Bray G.A, Aickin M, Conlin P.R, Miller E.R 3rd, Appel L.J. Effect of dietary sodium intake on blood lipids: results from the DASH-sodium trial. Hypertension 2004; 43: 393-398.
Fried S.K., Rao S.P. Sugars, hypertriglyceridemia, and cardiovascular disease. Am J Clin Nutrition 2003; 78: 873-880.
Howard D.V, Wylie J. Sugar and cardiovascular disease. A statement for health care professional from the Committee on Nutrition of the Council on Nutrition, Physical Activity and Metabolism of American Heart Association. Circulation 2002; 106: 523-527.
Yang E.J, Chung H.K, Kim W.V, et al. Carbohydrate intake is associated with diet quality and risk factors for cardiovascular disease in U.S. adults: NHANES III. J Am Coll Nutr. 2003; 22(1): 71-79.
Foster G.D, Wyatt H.R, Hill J.O, et al. F Randomized trial of a low-carbohydrate diet for obesity. N Engl J Med 2003; 348: 2082-2090.
Wolever T MS, Mehling C. Long-term effect of varying the source or amount of dietary carbohydrate on postprandial plasma glucose, insulin, triacylglycerol, and free fatty acid concentrations in subjects with impaired glucose tolerance. Am J Clin Nutr 2003; 77:612-621.
Dauchet L., Amouyel P, Hercberg S, Dallongeville J. Fruit and vegetable consumption and risk of coronary heart disease: a meta-analysis of cohort studies. J Nutr 2006; 136: 1-6.
Dauchet L., Amouyel P, Dallongeville J. Fruit and vegetable consumption and risk of stroke: a mets-analysis of cohort studies. Neurology 2005; 65: 1193 -1197.
Appel L.J, Sacks F.M, Carrey V.J, et al. Effects of protein, monounsaturated fat, and carbohydrate intake on blood pressure and serum lipids. Results of the OmniHeart randomized trial. JAMA 2005; 294: 2455-2464.
Tikkanen M., Högtröm P, Tuomilehto J, et al. Effect of a diet based on low-fat foods enriched with nonesterified plant sterols and mineral nutrients on serum cholesterol. Am J Cardiol 2001; 88: 1157-1162.
Федеральный закон "О потребительской корзине в целом по Российской Федерации", от 31 марта 2006 года.
Статистический сборник “Краткосрочные экономические показатели Российской Федерации”, Госкомстат России. Москва, 2008.
Marques-Vidal P, Arveiler D, Evans A, et al. Different alcohol drinking and blood pressure relationships in France and Northern Ireland. The PRIME Study. Hypertension. 2001; 38: 1361-1366.
Franco Oscar H, Bonneux Luc, de Laet Chris,, Peeters Anna, Steyerberg Ewout W, Mackenbach Johan P, The Polymeal: a more natural, safer, and probably tastier (than the Polypill) strategy to reduce cardiovascular disease by more than 75% BMJ 2004;329:1447-1450.
Grundy S.M, Cleeman J.I, Merz C.N, Brewer H.B et al. National Heart, Lung, and Blood Institute; American College of Cardiology Foundation; American Heart Association. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004; 110: 227–239.
Fung T.T, Willett W.C, Stampfer M.J, Manson J.E, Hu F.B. Dietary patterns and the risk of coronary heart disease in women. Archives of Internal Medicine 2001; 13-27; 161(15):1857-1862.
Xin X, He J, Frontini MG, et al. Effects of alcohol reduction on blood pressure. A Meta-analysis of randomized controlled trials. Hypertension 2001; 38: 1112-1117.
Beilin LJ., Puddey IB. Hypertension Highlights: Alcohol and Hypertension: An Update. Hypertension. 2006;47:1035-1038.
Константинов В.В., Деев А.Д., Капустина А.А. и др. Распространенность избыточной массы тела и ее связь со смертностью от сердечно-сосудистых и других хронических неинфекционных заболеваний среди мужского населения в городах разных регионов. Кардиология 2002; 10: 45-49.
WHO. Prevention and management of global epidemic of obesity. Report of WHO Consultation of obesity (Geneva, 3–5 June, 1997).
Здоровье населения в Европе - 1997. Региональная публикация ВОЗ. Европейская серия №83; 1998.
Здоровье России. Атлас. Под ред. Академика РАМН Бокерия Л.А. М; 2009.
Погожева А.В. Диетологические аспекты первичной профилактики сердечно-сосудистых заболеваний у женщин с избыточной массой тела. Сердце: журнал для практикующих врачей, 2004; 3(6):295-298.
Старостина Е.Г. Принципы рационального питания в терапии ожирения. Часть 1 Кардиология 2001;8: 87-92.
Лечение ожирения, рекомендации для врачей, под ред. Бутровой С..А., 2000.
Еганян Р.А., Калинина А.М., Карамнова Н.С., Измайлова О.В., Поздняков В.М. и др. Школа здоровья для пациентов с избыточной массой тела. Приложение 1 к Организационно-методическому письму Минздрава России от 5 марта 2004 года «Организация в первичном звене здравоохранения профилактической помощи лицам, желающим снизить избыточную массу тела»; М: 2006; 100с.
James W.P.T, Jackson-Leach r, Mhurdu C.N, Kalamara E, Shayeghi M, Rigby N, Nishida C and Rodgers A. Overweight and Obesity. In Comparative Quantification of Health Risks: Global and Regional Burden of Disease Attributable to Selected Major Risk Factors, eds. Ezzati M, Lopez AD, Rodgers A, Murray CJL, WHO, Geneva. 2003.
Hubert H.B, Feinleib M, McNamara P.M, Castelli W.P. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983; 67:968-977.
Перова Н.В., Метельская В.А. Ожирение ведет к атеросклерозу. Профил забол укреп здор 2004; 1: 40-45.
Чазова И.Е., Мычка В.Б. Метаболический синдром. М; Media Medica: 2004; 168.
Бритов А.Н., Молчанова О.В., Быстрова О.В. и др. Взаимосвязь уровня лептина с гемодинамическими показателями и постпрандиальной гликемией у пациентов с ожирением и артериальной гипертонией. Кардиоваск тер проф 2004; 3ч;11:27-30.
McTique K.M, Harris R, Hemphill B, et al. Screening and interventions for obesity in adults: summary of evidence for U.S. preventive services task force. Ann Intern Med. 2003; 139: 933-949.
Noakes M, Keogh J.B, Foster P.R, et al. Effect of an energy-restricted, high-protein, low-fat diet relative to a conventional high-carbohydrate, low-fat diet on weight loss, body composition, nutritional status, and markers of cardiovascular health in obese women. Am J Clinical Nutrition 2005; 81(6): 1298-1306.
Pelkman C.L, Fishell V.K, Maddox D.H, et al. Effects of moderated-fat (from monounsaturated fat) and low-fat weight-loss diets on the serum lipid profile in overweight and obese men on women. Am J Clin Nutr 2004; 79 (2): 204-212.
Poppitt S.D, Keogh G.F, Prentice A.M, et al. Long-term effects of ad libitum low-fat, high-carbohydrate diets on body weight and serum lipids in overweight subjects with metabolic syndrome. Am J Clin Nutr 2002; 75(1): 11-20.
Lefevre M, Champagne C, Tulley R.T, et al. Individual variability in cardiovascular disease risk factor responses to low fat and low saturated-fat diets in men body: mass index, adiposity, and insulin resistance predict changes in LDL cholesterol. Am J Clin Nutr 2005; 82 (5): 957-963.
Kelly S., Summerbell C. Prevention of obesity: a review. Obesity reviews 2007; 8; 1;127-130.
Klein S, Burke L.E, Bray G.A, Blair S, Allison D.B, Pi-Sunyer X, Hong Y, Eckel R.H; American Heart Association Council on Nutrition, Physical Activity, and Metabolism. Clinical implications of obesity with specific focus on cardiovascular disease: a statement for professionals from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation. Circulation 2004; 110: 2952–2967.
Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. The evidence report. NIH Publication, No. 98-4083. 1998.
Berghöfer A., Pischon T., Reinhold T., Apovian C.M. 3 , Sharma A.M., Willich S.N. Obesity prevalence from a European perspective: a systematic review. BMC Public Health 2008, 8:200 doi:10.1186/1471-2458-8-200.
U.S. Department of Health and Human Services. 2008 Physical Activity Guidelines for Americans. Be active, Healthy, and Happy! Public Health Service. 2008
Nocon M., Hiemann T., Müller-Riemenschneider F., Thalau F., Roll S., Willich S.N. Association of physical activity with all-cause and cardiovascular mortality: a systematic review and meta-analysis. J Cardiovasc Prevent Rehabil 2008;15(3):239–46.
Moholdt T., Wisløff U., Nilsen T.I.L., Slørdahl S.A. Physical activity and mortality in men and women with coronary heart disease: a prospective population-based cohort study in Norway (the HUNT study). J Cardiovasc Prevent Rehabil 2008; 15(6): 639-645.
Sofi F., Capalbo A., Cesari F., Abbate R., Gensini G.F. Physical activity during leisure time and primary prevention of coronary heart disease: an updated meta-analysis of cohort studies. J Cardiovasc Prevent Rehabil 2008; 15(3): 247-257.
Содействие физической активности в целях укрепления здоровья – основа для действий в Европейском регионе ВОЗ. Шаги по пути к физически более активной Европе. Всемирная организация здравоохранения. Европейское региональное бюро. 2006 г.
Р. А. Потемкина, И. С. Глазунов, Н. В. Вартапетова, И. М. Соловьева, Э. Г. Волкова, И. С. Петрухин, К. А. Похис. Оценка существующей в России практики в области профилактики сердечно-сосудистых и других неинфекционных заболеваний. Профилактика заболеваний и укрепление здоровья. 1998, 2, 46-48.
van Camp SP, Bloor CM, Mueller DO, et al. Non-traumatic sports death in high school and college athletes. Med Sci Sports Exerc. 1995;27:641-647.
Corrado D, Basso C, Rizzoli C, et al. Does sports activity enhance the risk of sudden death in adolescents and young adults? J Am Coll Cardiol. 2003;42:1959-1963.
Haskell WL. Cardiovascular complications during exercise training in cardiac patients. Circulation. 1978;57:920-925.
van Camp SP, Petterson RA. Cardiovascular complications of outpatient cardiac rehabilitation programs. JAMA. 1986;256:1160-1163.
Haskell WL. The efficacy and safety of exercise programs in cardiac rehabilitation. Med Sci Sports Exerc. 1994;26:815-823.
Vongvanaich P, Paul-Laborador MJ, Merz CNB. Safety of medically supervised exercise in a cardiac rehabilitation center. Am J Cardiol. 1996;77:1383-1385.
PACE. Physician Manual. Physician-based Assessment and Counseling for Exercise and Nutrition. Copyright © 1999 by San Diego University Foundation and San Diego Centre for Health Interventions.
Chakravarty EF, Hubert HB, Lingala VB, Zatarain E, Fries JF Long Distance Running and Knee Osteoarthritis A Prospective Study. Am J Prev Med. 2008 Aug;35(2):133-8.
Palatini P., Julius S. Heart rate and cardivascular risk. J Hypertens 1997;15: 3–17.
Gillum RF. Pulse rate, coronary artery disease, and death: the NHANES I Epidemiologic Follow-up Study. Am Heart J 1991;121:172-7.
Gillman M, Kannel W, Belanger A, D"Agostino R. Influence of heart rate on mortality among persons with hypertension: The Framingam study Am Heart J 1993;125:1148-54.
Sandvik L, Erikssen J, Ellestad M et al. Heart rate increase and maximal heart rate during exercise as predictors of cardiovascular mortality: a 16-year follow-up study of 1960 healthy men. Cor Art Dis 1995;6:667-79.
Sa Cunha R, Pannier B, Benetos et al. Association between high heart rate and hight arterial rigidity in normotensive and hypertensive subjects. J Hypertens 1997; 15: 1423-30.
Benetos A., Adamopoulos C., Bureau J.M. et al. Determinants of accelerated progression of arterial stiffnes in normotensive and treated hypertensive subjects over a 6-year period // Circulation. – 2002. - Vol. 105. – Р. 1202–7.
Shigetoh Y, Adachi H, Yamagishi S, Enomoto M, Fukami A, Otsuka M, Kumagae S, Furuki K, Nanjo Y, Imaizumi T. Higher heart rate may predispose to obesity and diabetes mellitus: 20-year prospective study in a general population. Am J Hypertens 2009; 22: 151-155.
Kaplan J, Manuck S, Adams M et al. Propranolol inhibits coronary atherosclerosis in behaviorally predisposed monkeys fed an atherogenic diet. Circulation 1987;761:1364-72.
Bonaa KH, Arnesen E. Association between heart rate and atherogenic blood lipid fractions in a population. The Tromso Study. Circulation 1992;86:394-405.
Huikuri H.V., Jokinen V., Syvanne M. et al. Heart rate variability and progression of coronary atherosclerosis. Arterioscler Thromb Vasc Biol 1999;19:1979–1985.
Bassiouny H.S., Zarins C.K., Kadowaki M.H. et al. Hemodynamic stress and experimental aortoiliac atherosclerosis. J Vasc Surg 1994;19:426–434.
Fusrer V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes (I). N Engl J Med 1992;326:242-50.
Shaper AG, Wannamethee G, Macfarlane PW, Walker M. Heart rate, ischaemic heart disease, and sudden cardiac death in middle-aged British men. Br Heart J 1993;70:49-55.
Hjalmarson A, Giplin EA, Kjekshus J et al Influence of heart rate on mortality after acute myocardial infarction. Am J Cardiol 1990;65:547-53.
Lee K.L., Woodlief L.H., Topol E.J. et al. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction: results from an international trail of 41,021 patients. GUSTO-I Investigators. Circulation 1995; 91:1659–1668.
Fox K, Ford I, Steg PG, Tendera M, Ferrari R; BEAUTIFUL Investigators. Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomized, double-blind, placebo-controlled trial. Lancet. 2008 Sep 6;372(9641):807-16.
Benetos A., Rudnichi A., Thomas F. et al. Influence of heart rate on mortality in a French population: role of age, gender and blood pressure. Hypertension 1999;33: 44–52.
Palatini P., Thijs L., Staessen J.A. et al. Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Predictive value of clinic and ambulatory heart rate for mortality in elderly subjects with systolic hypertension. Arch Intern Med 2002;162:2313–2321.
Шальнова С.А., Деев А.Д., Оганов Р.Г. и др. Частота пульса и смертность от сердечно-сосудистых заболеваний у российских мужчин и женщин. Результаты эпидемиологического исследования. Кардиология 2005;10: 45–50.
Levine HJ. Rest heart rate and life expectancy. J Am Coll Cardiol 1997;30:1104-6.
Seccareccia F., Pannozzo F., Dima F. et al. Heart rate as a predictor of mortality: the MATISS Project. Am J Public Health 2001; 91:1258-63.
Azbel MY. Universal biological scaling and mortality. Proc Natyl Acad Sci USA 1994;91:12453-7.
Hozawa A., Ohkubo T., Kikuya M. et al. Prognostic value of home heart rate for cardiovascular mortality in the general population: the Ohasama study. Am J Hypertens 2004;17:1005–1010.
Brophy J, Joseph L, Rouleau J. β-Blockers in congestive heart failure: a Bayesian meta-analysis. Ann Intern Med 2001; 134:550-560.
Fox K, Garcia MA, Ardissino D, Buszman P, Camici PG, Crea F, Daly C, De Backer G, Hjemdahl P, Lopez-Sendon J, Marco J, Morais J, Pepper J, Sechtem U, Simoons M, Thygesen K, Priori SG, Blanc JJ, Budaj A, Camm J, Dean V, Deckers J, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo J, Zamorano JL; Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology; ESC Committee for Practice Guidelines (CPG).Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Eur Heart J. 2006 Jun;27(11):1341-81. Epub 2006 May 30.
Van de Werf F, Bax J, Betriu A, Blomstrom-Lundqvist C, Crea F, Falk V, Filippatos G, Fox K, Huber K, Kastrati A, Rosengren A, Steg PG, Tubaro M, Verheugt F, Weidinger F, Weis M; ESC Committee for Practice Guidelines (CPG), Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Silber S, Aguirre FV, Al-Attar N, Alegria E, Andreotti F, Benzer W, Breithardt O, Danchin N, Di Mario C, Dudek D, Gulba D, Halvorsen S, Kaufmann P, Kornowski R, Lip GY, Rutten F. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J. 2008 Dec;29(23):2909-45. Epub 2008 Nov 12.
Task Force for Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of European Society of Cardiology, Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, Strömberg A, van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K; ESC Committee for Practice Guidelines, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL.ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM).Eur Heart J. 2008 Oct;29(19):2388-442.
Национальные клинические рекомендации «Диагностика и лечение артериальной гипертонии». Кардиоваскулярная терапия и профилактика 2008, 7(6), приложение 2.
American Diabetes Association. Standards of medical care in diabetes—2010. Diabetes Care 2010; 33(suppl 1):S11-S61.
Scheen AJ. Clinical study of the month. Premature interruption of ASCOT and CARDS clinical trials of cardiovascular prevention with atorvastatin in patients with arterial hypertension or diabetes mellitus: compromise between ethics and statistics in evidence-based medicine. Rev Med Liege. 2003 Sep;58(9):585-90. French.
Plosker GL, Lyseng-Williamson KA. Atorvastatin: a pharmacoeconomic review of its use in the primary and secondary prevention of cardiovascular events. Pharmacoeconomics. 2007;25(12):1031-53.
Gaspardone A, Arca M. Atorvastatin: its clinical role in cerebrovascular prevention. Drugs. 2007;67 Suppl 1:55-62.
Birkenhäger WH, Staessen JA, Gasowski J, de Leeuw PW. Effects of antihypertensive treatment on endpoints in the diabetic patients randomized in the Systolic Hypertension in Europe (Syst-Eur) trial. J Nephrol. 2000 May-Jun;13(3):232-7.
Y. Yamori, T. Taguchi, A. Hamada, K. Kunimasa, H. Mori, M. Mori.Таурин в норме и патологии: результаты экспериментальных и эпидемиологических исследований. Journal of Biomedical Science, 2009: Vol.17 Suppl.1. РКЖ 6-2010, 64-75.
|
